Astellas Takes Option on Audax IL12 Fusion
Astellas and Australia-based Audax announced an exclusive worldwide option and license for preclinical DAX-044 on 28 October. The disclosed potential value is $1.34 billion excluding royalties, but the actual upfront amount is not separated…
